2025-11-18
— Fourth Annual · Second Phase of the Investment Sharing Club Officially Commences

65 Equity Partners focuses on emerging markets, private equity, fixed income, and real estate investments.
The company has long adhered to the philosophy of “prudent investing and long-term value creation”, providing global investors with steady and sustainable growth opportunities through in-depth market research and rigorous risk management.
"Creating Alpha with Vision, Building the Future with Action"
65 Equity Partners, an independent investment platform wholly owned by Temasek Holdings, officially announces the launch of the “Alpha Vision Investment Program.”
The program concentrates on global asset allocation, private equity, and regional market investment opportunities, aiming to help investors achieve steady growth and generate excess returns (Alpha) amid market volatility.
Strategic Partnership to Co-Create Value
In collaboration with Malaysia's top financial institutions, Maybank, Public Bank, CIMB Group, and multiple international investment partners, 65 Equity Partners Private Equity Club was jointly established. The investment club has now completed its fourth year of operation.
Through research-driven investment decisions and a systematic education framework, the club provides investors with professional investment guidance and one-on-one strategic consultation, building a trusted wealth collaboration platform.
Instructor Su Sheng focuses on global regions and the Malaysian market, analyzing economic trends and investment opportunities with professional insights. He helps members grasp market dynamics, expand forward-looking thinking, and seek stability and growth in uncertain times.
65 Equity Partners: www.65ep.net
Address: 501 Orchard Road, #11-01 Wheelock Place, Singapore
CGTN: How China embraces the world with open arms, boosts development for all
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
©copyright 2009-2020 Singapore Info Map